Self-reported adverse events within the seven days following the Spikevax® (Moderna) vaccination Dulce Guerra-Estévez; Cristina Palomo-Palomo; Alberto Parrado-González; Juila Estaire-Gutiérrez; Miguel Reyes-Malia; M. Mercedes Romero-Alonso;

Reactogenicity of the BNT162b2 mRNA vaccine (Pfizer-BioNTech) against COVID-19 in workers of a tertiary hospital Cristina Palomo-Palomo; Dulce Guerra-Estévez; Alberto Parrado-González; Julia Estaire-Gutiérrez; Miguel Reyes-Malia; M. Mercedes Romero-Alonso;

Adverse reactions to radiopharmaceuticals Juan Antonio Pérez-Iruela; Purificación Pastor-Fructuoso; Carla de Gracia-Rodríguez; Marta Soler-Vigil; María del Val Gómez-Martínez;